X. Wei Meng

2.1k citations

31 papers · 1.4k indexed · h-index 21

Impact in

Molecular Biology top 10%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- Ubiquitin and proteasome pathways
Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways

Papers in

Virology 2
Oncology 10
- Cancer-related Molecular Pathways 6
- PARP inhibition in cancer therapy 5

Co-authors: Scott H. Kaufmann Haiming Dai Sun Hee Lee Paula A. Schneider Karen S. Flatten Husheng Ding D A Loegering Yuan‐Ping Pang
Journals: Journal of Biological Chemistry (5 papers)Cell Death and Differentiation (4 papers)The Journal of Cell Biology (3 papers)Cell Death and Disease (2 papers)APOPTOSIS (2 papers)
Partner nations: United States China Australia

In The Last Decade

X. Wei Meng

30 papers receiving 1.4k citations

Peers

Countries citing papers authored by X. Wei Meng

Since Specialization

Citations

This map shows the geographic impact of X. Wei Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Wei Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Wei Meng more than expected).

Fields of papers citing papers by X. Wei Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Wei Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Wei Meng. The network helps show where X. Wei Meng may publish in the future.

Co-authors

The 25 scholars most cited alongside X. Wei Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with X. Wei Meng Line = papers co-authored together X. Wei Meng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Solution for EEG Acquisition Device Based on ESP32-S3 and LH7909 X. Wei Meng, Y. Zhu, 美砂子宮下, Gioia Zanfino	2024	0
2	Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson’s Disease Parkinson s Disease ·Julien Ployé, Edris Khezri, X. Wei Meng, Ulrich Schmid, Khofifatul Amalia, С. Ю. Бердинских, Xinling Yang	2023	5
3	ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance Nucleic Acids Research ·Julia O’Sullivan, Charu Kothari, Marie‐Christine Caron, Jean‐Philippe Gagné, Zhigang Jin, 浩光丹野, Adriano F. de Figueiredo, Yan Coulombe, Mélissa Thomas, Muhammad Waleed Hasan, X. Wei Meng, H-W Wollenweber, Dominique Jean, François‐Michel Boisvert, Scott H. Kaufmann, Michael J. Hendzel, Jean‐Yves Masson, Guy G. Poirier	2023	6
4	A BAK subdomain that binds mitochondrial lipids selectively and releases cytochrome C Cell Death and Differentiation ·Haiming Dai, Kevin L. Peterson, Karen S. Flatten, X. Wei Meng, Elango Shanmugam, Cristina Correia, Marina Ramı́rez-Alvarado, Yuan‐Ping Pang, Scott H. Kaufmann	2022	10
5	Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells Cell Death and Disease ·Barbara Schroeder, Thomas Wozniak, Ingrid Espinoza, Daryna Dehtiar, Zeng Hu, John C. Beyke, Kevin M. Regan, Elisabet Cuyàs, X. Wei Meng, Sara Verdura, Yang Jiang, Paula A. Schneider, Karen S. Flatten, George Kemble, Joan Montero, Scott H. Kaufmann, Javier A. Menéndez, Ruth Lupu	2021	62
6	Measurement of BH3-only protein tolerance Cell Death and Differentiation ·Haiming Dai, Husheng Ding, Kevin L. Peterson, X. Wei Meng, Paula A. Schneider, Katherine Knorr, Scott H. Kaufmann	2017	20
7	In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma Gynecologic Oncology ·Mariam AlHilli, Marc A. Becker, S. John Weroha, Karen S. Flatten, Rachel M. Hurley, Maria I. Harrell, Ann L. Oberg, 冬子, Kieran Hawthorne, Xiaonan Hou, Sean C. Harrington, Danyelle de Andrade Paula, X. Wei Meng, Keith Wilcoxen, Kimberly R. Kalli, Elizabeth M. Swisher, Scott H. Kaufmann, Paul Haluska	2016	49
8	Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells Genes & Development ·Haiming Dai, Husheng Ding, X. Wei Meng, Kevin L. Peterson, Paula A. Schneider, Judith E. Karp, Scott H. Kaufmann	2015	40
9	Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Cristina Correia, Sun Hee Lee, X. Wei Meng, Nicole D. Vincelette, Katherine Knorr, Husheng Ding, Grzegorz S. Nowakowski, Haiming Dai, Scott H. Kaufmann	2015	126
10	Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells Cell Death and Disease ·Zhang Js, Marta Herreros‐Villanueva, Alexander Köenig, Zhi-Hui Deng, 正雄豊田, Timothy S. Gomez, X. Wei Meng, Luís Bujanda, Volker Ellenrieder, N. N. Fefelov, Scott H. Kaufmann, Daniel D. Billadeau	2014	56
11	Contribution of Bcl-2 Phosphorylation to Bak Binding and Drug Resistance Cancer Research ·Haiming Dai, Husheng Ding, X. Wei Meng, Sun Hee Lee, Paula A. Schneider, Scott H. Kaufmann	2013	77
12	CXCR4 Chemokine Receptor Signaling Induces Apoptosis in Acute Myeloid Leukemia Cells via Regulation of the Bcl-2 Family Members Bcl-XL, Noxa, and Bak Journal of Biological Chemistry ·Kimberly N. Kremer, Kevin L. Peterson, Paula A. Schneider, X. Wei Meng, Haiming Dai, Allan D. Hess, B. Douglas Smith, Albert Mario Antônio L. C e Von Cornides, Judith E. Karp, Scott H. Kaufmann, Karen E. Hedin	2013	57
13	Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells Haematologica ·Husheng Ding, John S. McDonald, Seongseok Yun, P A Schneider, Kevin L. Peterson, Karen S. Flatten, D A Loegering, Ann L. Oberg, Shaun M. Riska, Shenglin Huang, Frank A. Sinicrope, Alex A. Adjei, Joddy Christyawan, X. Wei Meng, Scott H. Kaufmann	2013	25
14	Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm Cell Death and Differentiation ·Sun Hee Lee, X. Wei Meng, Karen S. Flatten, D A Loegering, Scott H. Kaufmann	2012	168
15	Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization The Journal of Cell Biology ·Haiming Dai, Alyson Smith, X. Wei Meng, Paula A. Schneider, Yuan‐Ping Pang, Scott H. Kaufmann	2011	123
16	Death Receptor 5 Signaling Promotes Hepatocyte Lipoapoptosis Journal of Biological Chemistry ·Sophie C. Cazanave, Justin L. Mott, Steven F. Bronk, Nathan W. Werneburg, Christian D. Fingas, X. Wei Meng, Niklas K. Finnberg, Wafik S. El‐Deiry, Scott H. Kaufmann, Gregory J. Gores	2011	102
17	Apoptosis-associated caspase activation assays Methods ·Scott H. Kaufmann, Sun Hee Lee, X. Wei Meng, David A. Loegering, Timothy Kottke, Osvaldo A. F. A. Tivane, Sandrine Ruchaud, Kumiko Samejima, William C. Earnshaw	2008	67
18	Lack of Correlation between Caspase Activation and Caspase Activity Assays in Paclitaxel-treated MCF-7 Breast Cancer Cells Journal of Biological Chemistry ·Timothy Kottke, April L. Blajeski, X. Wei Meng, Phyllis A. Svingen, Sandrine Ruchaud, Peter W. Mesner, Scott A. Boerner, Kumiko Samejima, Mario Melchionna, Tamie J. Chilcote, Janet M. Lord, M Salmon, William C. Earnshaw, Scott H. Kaufmann	2002	64
19	Iatrogenic GB virus C/hepatitis G virus infection in an area endemic for hepatitis C virus Journal of Hospital Infection ·Shigetoshi Ohshima, Masafumi Komatsu, Kunio Nakane, X. Wei Meng, Takashi Goto, Tomoki Fujii, Kazuo Yoneyama, Yoshiyuki Wada, F Tobori, Motokazu Mukaide, Osamu Masamune, Sumio Watanabe	2000	11
20	An investigation of a possible role for mitochondrial nuclease in apoptosis APOPTOSIS ·X. Wei Meng, Murray Fraser, Neil Querengesser, John M. Feller, John B. Ziegler	1998	4

About X. Wei Meng

X. Wei Meng is a scholar working on Virology, Oncology, Molecular Biology, Immunology and Cancer Research, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (18 papers), Cancer-related Molecular Pathways (6 papers), RNA Interference and Gene Delivery (5 papers), PARP inhibition in cancer therapy (5 papers), Mitochondrial Function and Pathology (3 papers), Liver Disease Diagnosis and Treatment (3 papers), NF-κB Signaling Pathways (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Molecular Biology (901 citations), Oncology (335 citations), Immunology (246 citations), Cancer Research (162 citations) and Hematology (103 citations). X. Wei Meng has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Scott H. Kaufmann, Haiming Dai, Sun Hee Lee, Paula A. Schneider, Karen S. Flatten, Husheng Ding, D A Loegering, Yuan‐Ping Pang, Alyson Smith and Katherine Knorr. Their work appears in journals such as Journal of Biological Chemistry, Cell Death and Differentiation, The Journal of Cell Biology, Cell Death and Disease and APOPTOSIS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact